MX336974B - Una vacuna dirigida contra la pleuroneumonia porcina, y un metodo para obtener dicha vacuna. - Google Patents

Una vacuna dirigida contra la pleuroneumonia porcina, y un metodo para obtener dicha vacuna.

Info

Publication number
MX336974B
MX336974B MX2012001577A MX2012001577A MX336974B MX 336974 B MX336974 B MX 336974B MX 2012001577 A MX2012001577 A MX 2012001577A MX 2012001577 A MX2012001577 A MX 2012001577A MX 336974 B MX336974 B MX 336974B
Authority
MX
Mexico
Prior art keywords
vaccine
directed against
against porcine
porcine pleuropneumonia
pleuropneumonia
Prior art date
Application number
MX2012001577A
Other languages
English (en)
Other versions
MX2012001577A (es
Inventor
Henricus Leo Bernardus Maria Klaasen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2012001577A publication Critical patent/MX2012001577A/es
Publication of MX336974B publication Critical patent/MX336974B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una vacuna dirigida contra la pleuroneumonía porcina, que comprende lipopólisacárido que se origina a partir de Actinobacillus pleuropneumoniae purificado de un cultivo bacteriano en combinación con uno o más repeticiones en toxinas Apxl, Apxll y Apxlll en forma de un complejo, dicha vacuna catacterizada porque comprende una polimixina que se selecciona de polimixina B, polimixina E, polimixina M y nonapéptido de polimixina para reducir los síntomas de un choque endotóxico que surge del lipopolisacárido.
MX2012001577A 2009-08-06 2010-08-05 Una vacuna dirigida contra la pleuroneumonia porcina, y un metodo para obtener dicha vacuna. MX336974B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23182009P 2009-08-06 2009-08-06
EP09167342 2009-08-06
PCT/EP2010/061387 WO2011015614A1 (en) 2009-08-06 2010-08-05 A vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine

Publications (2)

Publication Number Publication Date
MX2012001577A MX2012001577A (es) 2012-03-26
MX336974B true MX336974B (es) 2016-02-05

Family

ID=42199110

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001577A MX336974B (es) 2009-08-06 2010-08-05 Una vacuna dirigida contra la pleuroneumonia porcina, y un metodo para obtener dicha vacuna.

Country Status (12)

Country Link
US (2) US20120128712A1 (es)
EP (2) EP2461823B1 (es)
JP (1) JP5847713B2 (es)
KR (1) KR101790357B1 (es)
CN (1) CN102481350B (es)
BR (1) BR112012002583B1 (es)
DK (1) DK2461823T3 (es)
ES (1) ES2492675T3 (es)
MX (1) MX336974B (es)
RU (1) RU2554812C2 (es)
TW (1) TWI548746B (es)
WO (1) WO2011015614A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010319678A1 (en) * 2009-11-10 2012-05-17 Boehringer Ingelheim Vetmedica, Inc. Actinobacillus suis antigens
TWI693231B (zh) * 2015-04-28 2020-05-11 金協國際實業有限公司 豬胸膜肺炎放線桿菌重組毒素蛋白及其應用
CN104998256A (zh) * 2015-07-14 2015-10-28 天津瑞普生物技术股份有限公司 一种猪用三联灭活疫苗的制备方法
KR102018707B1 (ko) 2017-07-31 2019-09-06 주식회사 고려비엔피 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
BR112020012137A2 (pt) * 2017-12-20 2020-11-24 Intervet International B.V. vacina para proteger um porco contra actinobacillus pleuropneumoniae

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0453024B1 (en) 1990-04-20 1995-05-31 Akzo Nobel N.V. Actinobacillus pleuropneumoniae subunit vaccine
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
JPH05262666A (ja) * 1992-03-24 1993-10-12 Biseibutsu Kagaku Kenkyusho:Kk 豚胸膜肺炎多価ワクチン
US5545721A (en) * 1992-12-21 1996-08-13 Ophidian Pharmaceuticals, Inc. Conjugates for the prevention and treatment of sepsis
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1871787A2 (en) * 2005-04-11 2008-01-02 Sanofi Pasteur Polymyxin b analogs for lps detoxification

Also Published As

Publication number Publication date
EP2769734A1 (en) 2014-08-27
TW201109439A (en) 2011-03-16
BR112012002583B1 (pt) 2020-11-24
DK2461823T3 (da) 2014-07-21
ES2492675T3 (es) 2014-09-10
BR112012002583A2 (pt) 2016-03-22
RU2554812C2 (ru) 2015-06-27
JP5847713B2 (ja) 2016-01-27
WO2011015614A1 (en) 2011-02-10
EP2461823B1 (en) 2014-06-04
US20120128712A1 (en) 2012-05-24
JP2013501028A (ja) 2013-01-10
RU2012108227A (ru) 2013-09-20
CN102481350A (zh) 2012-05-30
MX2012001577A (es) 2012-03-26
CN102481350B (zh) 2017-04-05
EP2461823A1 (en) 2012-06-13
KR101790357B1 (ko) 2017-10-25
TWI548746B (zh) 2016-09-11
KR20120054037A (ko) 2012-05-29
US20160213768A1 (en) 2016-07-28

Similar Documents

Publication Publication Date Title
PH12018501602A1 (en) Subunit immersion vaccines for fish
HRP20180946T1 (hr) Postupak za preradu pepela, osobito letećeg pepela
BR112012029917A2 (pt) composições de nanotransportador com adjuvante desacoplado
GB201103836D0 (en) Conjugation process
MX340814B (es) Collar de limite mejorado.
FR2944106B1 (fr) Methode de dosage de l'inositol hexaphosphate (ihp).
NZ590324A (en) Vaccine against amyloid folding intermediate
MX336974B (es) Una vacuna dirigida contra la pleuroneumonia porcina, y un metodo para obtener dicha vacuna.
MX2010000724A (es) Metodo para reducir presion intracraneal.
UA102097C2 (ru) Способ лечения воспалительного заболевания с применением соединения, которое нейтрализует gm-csf, и соединения, которое нейтрализует il-17
IT1397886B1 (it) Procedimento per la produzione di componenti di carburanti per autotrazione.
EA201792593A1 (ru) Пестивирусные вакцины против врожденного тремора
ITVR20090005U1 (it) Dispositivo di contenimento, cosiddetto dispositivo fermaneve, paravalanghe, paramassi, o simile dispositivo.
CR20110533A (es) Compuesto de pirazol
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
AP2012006275A0 (en) The use of an L3 and/or L5 source as a vaccine or as a diagnostic for a parasitic disease.
HK1180055A1 (zh) 通過動態的語言引擎捕捉遙測數據
IL219840A0 (en) Alkaline alpha galactosidase for the treatment of fabry disease
EA201100132A1 (ru) Единичная доза ападеносона
MX2011012460A (es) Proceso para la preparacion de olmesartan medoxomil.
TN2012000014A1 (en) Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe)
IT1399581B1 (it) Dispositivo per la protezione di parti del corpo di un individuo, in particolare per la protezione della schiena.
Gyeltshen Essence Drops of Gold, An Account of Korphu Consecration
周君红 gkh

Legal Events

Date Code Title Description
FG Grant or registration